Teijin
Tsutomu "Tom" Igawa is an experienced executive in the healthcare and pharmaceutical sectors, currently serving as Chief Global Administration Officer and Chief Officer of Global Business Strategy at Teijin Limited since April 2019. Prior to this role, Igawa was Chairman of the Board at Teijin Pharma USA, LLC from April 2011 to September 2018 and served as Chief Governance Officer at Pacific Pulmonary Services during the same period. Igawa's extensive background at Teijin includes significant leadership positions such as GM of the Business Strategy Department and USA Home Healthcare Business Department, as well as various managerial roles in planning and controlling. Igawa began the career at Teijin Ltd in September 1985, working through multiple positions until December 2006. Igawa holds a Bachelor of Commerce degree in International Business from Waseda University, obtained between 1981 and 1985.
Teijin
1 followers
TEIJIN LIMITED is involved in the manufacture, processing and sale of chemical products. Advanced Fibers & Composites segment is engaged in the manufacture and sale of aramid fiber (such as yarn, cotton, woven or knitted fabric), carbon fiber products and polyester fiber (industrial materials). Electric Materials & Chemical Products segment involves in the manufacture and sale of films, resins and resin products. Healthcare segment involves in the manufacture and sale of pharmaceuticals and home medical care equipment, as well as the clinical development of new drugs. Products Converting segment involves in the planning, processing and sale of textile products. Others segment involves in the operation, development and maintenance of information systems, as well as the provision of printing services.